Get the Stockscreener App
22.15
1.86%
-0.42
After Hours:
22.15
Elanco Animal Health Inc stock is traded at $22.15, with a volume of 5.53M.
It is down -1.86% in the last 24 hours and up +9.98% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$22.57
Open:
$22.52
24h Volume:
5.53M
Relative Volume:
0.78
Market Cap:
$11.00B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
55.37
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
+0.45%
1M Performance:
+9.98%
6M Performance:
+133.65%
1Y Performance:
+75.24%
1-Day Range:
$22.13
$22.84
1-Week Range:
$21.80
$22.86
52-Week Range:
$8.02
$22.86
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
2500 INNOVATION WAY, GREENFIELD
Compare ELAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
22.15 | 11.21B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-17-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-26-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
How Expanded Parasiticide Approvals and Emergency Use Authorization at Elanco (ELAN) Have Changed Its Investment Story - simplywall.st
Is Elanco Animal Health Incorporated stock bottoming outWeekly Trend Summary & Community Trade Idea Sharing Platform - newser.com
Will Elanco Animal Health Incorporated stock recover faster than marketWeekly Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Is Elanco Animal Health Incorporated stock cheap at current valuationEarnings Growth Summary & Consistent Return Strategy Ideas - newser.com
How to integrate Elanco Animal Health Incorporated into portfolio analysis toolsInflation Watch & Verified Stock Trade Ideas - newser.com
How cyclical is Elanco Animal Health Incorporated (5EA) stock compared to rivalsGap Down & Verified Momentum Stock Watchlist - newser.com
Elanco Animal Health Incorporated stock prediction for this weekJuly 2025 Selloffs & Expert-Curated Trade Recommendations - newser.com
Risk vs reward if holding onto Elanco Animal Health IncorporatedWeekly Earnings Recap & Verified Short-Term Plans - newser.com
What insider purchases suggest about Elanco Animal Health Incorporated (5EA) stockWeekly Profit Summary & AI Optimized Trade Strategies - newser.com
Is Elanco Animal Health Incorporated meeting your algorithmic filter criteriaWeekly Trade Review & Safe Entry Trade Signal Reports - newser.com
Elanco Animal Health (NYSE:ELAN) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
Elanco Animal Health Incorporated’s volatility index tracking explainedMarket Trend Report & AI Driven Price Forecasts - newser.com
Jennison Associates LLC Has $46.19 Million Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Will Elanco Animal Health Incorporated (5EA) stock boost dividends furtherEarnings Overview Summary & Stock Portfolio Risk Management - newser.com
Elanco Animal Health Hits New 52-Week High of $22.86 - Markets Mojo
Companion Animal Health Market to Worth USD 61.74 Billion by 2034, Driven by Rising Pet Ownership and Humanization Trends - GlobeNewswire Inc.
Is Elanco Animal Health Incorporated (5EA) stock attractive for growth fundsWeekly Investment Recap & Expert Curated Trade Ideas - newser.com
What high frequency data says about Elanco Animal Health IncorporatedMarket Growth Review & Free Technical Pattern Based Buy Signals - newser.com
Is Elanco Animal Health Incorporated (5EA) stock a buy on weaknessQuarterly Portfolio Review & Daily Momentum Trading Reports - newser.com
News impact scoring models applied to Elanco Animal Health IncorporatedSell Signal & Real-Time Buy Zone Alerts - newser.com
Why Elanco Animal Health Incorporated (5EA) stock stays resilientJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
Will Elanco Animal Health Incorporated (5EA) stock benefit from infrastructure billTrade Risk Assessment & Free High Return Stock Watch Alerts - newser.com
Rising Trends of Thermostable Poultry Vaccine Market Growth - openPR.com
Is Elanco Animal Health Incorporated stock poised for growthExit Point & Daily Stock Trend Reports - newser.com
Will Elanco Animal Health Incorporated stock benefit from Fed rate cutsWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
Published on: 2025-10-30 23:29:20 - newser.com
Elanco Animal Health Hits New 52-Week High of $22.73 - Markets Mojo
Elanco's Credelio™ (Lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) Against New World Screwworm (NWS) in Dogs - ReportAlert
Elanco Animal Health (ELAN) to Release Quarterly Earnings on Wednesday - MarketBeat
Published on: 2025-10-30 06:31:33 - newser.com
Elanco Animal Health (XTRA:5EA) Price Target Decreased by 25.68% to 19.01 - Nasdaq
Elanco, pet retailers say plaintiffs waited too long to amended US antitrust complaint - MLex
Elanco Animal Health Incorporated (ELAN) Reports Next Week: What You Should Expect - Yahoo Finance
Will breakout in Elanco Animal Health Incorporated lead to full recovery2025 Biggest Moves & Free Safe Capital Growth Stock Tips - newser.com
Companion Animal Health Industry Insights 2025 | Expanding - openPR.com
Published on: 2025-10-29 04:01:33 - newser.com
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):